Neuropeptide Y and its receptors as potential therapeutic drug targets

Clin Chim Acta. 2002 Dec;326(1-2):3-25. doi: 10.1016/s0009-8981(02)00301-7.


Neuropeptide Y (NPY) is a 36-amino-acid peptide that exhibits a large number of physiological activities in the central and peripheral nervous systems. NPY mediates its effects through the activation of six G-protein-coupled receptor subtypes named Y(1), Y(2), Y(3), Y(4), Y(5), and y(6). Evidence suggests that NPY is involved in the pathophysiology of several disorders, such as the control of food intake, metabolic disorders, anxiety, seizures, memory, circadian rhythm, drug addiction, pain, cardiovascular diseases, rhinitis, and endothelial cell dysfunctions. The synthesis of agonists and antagonists for these receptors could be useful to treat several of these diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Neuropeptide Y / pharmacology*
  • Neuropeptide Y / physiology
  • Receptors, Neuropeptide Y / agonists*
  • Receptors, Neuropeptide Y / antagonists & inhibitors*
  • Receptors, Neuropeptide Y / classification
  • Receptors, Neuropeptide Y / physiology
  • Signal Transduction / physiology


  • Neuropeptide Y
  • Receptors, Neuropeptide Y